Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)
Status:
Terminated
Trial end date:
2017-12-14
Target enrollment:
Participant gender:
Summary
The primary objective of this Non Interventional Study is to measure changes in physical
functioning, a surrogate for physical activity and exercise capacity, in COPD patients on
treatment with Spiolto® Respimat® in routine daily treatment after approximately 6 weeks.
A secondary objective is to evaluate the patient's general condition (physician's evaluation)
from Visit 1 (baseline visit at the start of the study) to Visit 2 (final visit at the end of
the study, approx. 6 weeks after Visit 1), as well as patient satisfaction with Spiolto®
Respimat® at Visit 2.